Monashee Investment Management LLC Immunovant, Inc. Transaction History

Monashee Investment Management LLC

  • $704 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$30.27 - $43.79 $908,100 - $1.31 Million
30,000 Added 42.86%
100,000 $3.23 Million
Q4 2023

Feb 12, 2024
SELL
$31.31 - $44.19 $3.13 Million - $4.42 Million
-100,000 Reduced 58.82%
70,000 $2.95 Million
Q3 2023

Nov 13, 2023
BUY
$18.55 - $39.96 $3.15 Million - $6.79 Million
170,000 New
170,000 $6.53 Million
Q4 2020

Feb 11, 2021
SELL
$36.36 - $52.71 $1.82 Million - $2.64 Million
-50,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$22.61 - $38.9 $1.13 Million - $1.95 Million
50,000 New
50,000 $1.76 Million

Others Institutions Holding IMVT

# of Institutions
220
Shares Held
65.1M
Call Options Held
697K
Put Options Held
629K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email